Kilitch Drugs (India) Share Price
175.05+2.53 (+1.47%)
-1.75% past 1 Year
News
Kilitch Drugs begins nutraceutical production at new Raigad manufacturing unit
Equity
KILITCH
Kilitch Drugs Approves 1:1 Bonus Share Issue; Board Meeting on 11th February 2026
Equity
KILITCH
Kilitch Drugs Q3 FY26 EBITDA Declines to Rs 6.20 Crores, Margin at 11.45% YoY.
Equity
KILITCH
Kilitch Drugs Q3 FY26 Results: Net Profit Declines 26.67% YoY to Rs 4.40 Crores
Equity
KILITCH
Kilitch Drugs (India) consolidated Q2 profit marginally down, EBITDA margin improves YoY, revenue up modestly
Equity
KILITCH
Kilitch Drugs(India) reports Profit after tax of 4.79 Crores, in the June 2025 quarter
Equity
KILITCH
Kilitch Drugs(India) - Quaterly Results
Equity
KILITCH
Kilitch Drugs(India) - Quaterly Results
Equity
KILITCH
Kilitch Drugs: Q1 Ebitda 3.30 Crores Rupees Vs 1.70 Crores (Yoy) || Q1 Ebitda Margin 7.56% Vs 4.96% (Yoy)
Equity
KILITCH
Kilitch Drugs: Q1 Cons Net Profit 3.00 Crores Rupees Vs 1.30 Crores (Yoy) || Q1 Revenue 43.10 Crores Rupees Vs 33.50 Crores (Yoy)
Equity
KILITCH
Kilitch Drugs India informs about board meeting
Equity
KILITCH
Kilitch Drugs: Co Board Approves Rights Issue Price At 357 Rupees Per Share. ???
Equity
KILITCH
Kilitch Drugs: Q4 Ebitda 13.91 Crores Rupees Vs 5.20 Crores (Yoy) || Q4 Ebitda Margin 24.7% Vs 13.33% (Yoy)
Equity
KILITCH
Kilitch Drugs: Q4 Revenue 56.30 Crores Rupees Vs 39.10 Crores (Yoy)
Equity
KILITCH
Kilitch Drugs: Q4 Sl Net Profit 10.44 Crores Rupees Vs 4.68 Crores (Yoy); 5.65 Crores (Qoq)
Equity
KILITCH
Kilitch Drugs (India): Q3 Ebitda 8.70 Crores Rupees Vs 2.30 Crores (Yoy) || Q3 Ebitda Margin 15.54% Vs 7.14% (Yoy)
Equity
KILITCH
Kilitch Drugs (India): Q3 Cons Net Profit 6.00 Crores Rupees Vs 2.90 Crores (Yoy); 8.60 Crores (Qoq) || Q3 Revenue 56.20 Crores Rupees Vs 31.80 Crores (Yoy)
Equity
KILITCH
Kilitch Drugs (India): Co Invests $200,000 In Kilitch Estro Biotech
Equity
KILITCH
Kilitch Drugs (India): Q2 Net Profit 8.60 Crores Rupees Vs 4.70 Crores (Yoy) || Q2 Revenue 47.50 Crores Rupees Vs 41.20 Crores (Yoy)
Equity
KILITCH
Kilitch Drugs (India): Q4 Ebitda 5.22 Crores Rupees Vs 6.69 Crores (Yoy) || Q4 Ebitda Margin 13.33% Vs 15.45% (Yoy)
Equity
KILITCH